LEADER 01945nam  2200385   450 
001 9910688208303321
005 20230625095934.0
035   $a(CKB)5400000000045552
035   $a(NjHacI)995400000000045552
035   $a(EXLCZ)995400000000045552
100   $a20230625d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMuscle cell and tissue $enovel molecular targets and current advances /$fedited by Kunihiro Sakuma, Nobuo Morotomi
210  1$aLondon :$cIntechOpen,$d[2021]
210  4$dİ2021
215   $a1 online resource (130 pages) $cillustrations
311   $a1-83968-652-9 
320   $aIncludes bibliographical references.
330   $aThe loss of skeletal muscle mass and strength substantially impairs physical performance and quality of life. This book details some approaches to the treatment of muscle wasting. It also reviews novel applications against pulmonary arterial hypertension such as cell reprogramming and the use of anticancer drugs that induce programmed cell death. Vascular smooth muscle cells (VSMCs) are the most prevalent cell types in blood vessels and serve critical regulatory roles. This publication also introduces mathematical models concerning the molecular mechanism and targets of cyclic guanosine 3',5'-monophosphate (cGMP) in the contraction of VSMCs. This book will be of interest to professionals in clinical practice, medical and health care students, and researchers working in muscle-related fields of science.
517   $aMuscle Cell and Tissue 
606   $aMuscles$xDiseases
615  0$aMuscles$xDiseases.
676   $a616.74
702   $aSakuma$b Kunihiro
702   $aMorotomi$b Nobuo
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688208303321
996   $aMuscle Cell and Tissue$92280361
997   $aUNINA